These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 29496051)

  • 1. Baseline peripheral blood leukocytosis: Biological marker predicts outcome in oropharyngeal cancer, regardless of HPV-status.
    Gouw ZAR; Paul de Boer J; Navran A; van den Brekel MWM; Sonke JJ; Al-Mamgani A
    Oral Oncol; 2018 Mar; 78():200-206. PubMed ID: 29496051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oropharyngeal cancer prognosis by tumour HPV status in France: The multicentric Papillophar study.
    Lacau St Guily J; Rousseau A; Baujat B; Périé S; Schultz P; Barry B; Dufour X; Malard O; Pretet JL; Clavel C; Birembaut P; Franceschi S;
    Oral Oncol; 2017 Apr; 67():29-36. PubMed ID: 28351578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Patients with Human Papillomavirus-Positive Oropharyngeal Cancer.
    So YK; Lee G; Oh D; Byeon S; Park W; Chung MK
    Otolaryngol Head Neck Surg; 2018 Aug; 159(2):303-309. PubMed ID: 29557259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of pretreatment circulating neutrophils, monocytes, and lymphocytes in oropharyngeal cancer stratified by human papillomavirus status.
    Huang SH; Waldron JN; Milosevic M; Shen X; Ringash J; Su J; Tong L; Perez-Ordonez B; Weinreb I; Bayley AJ; Kim J; Hope A; Cho BC; Giuliani M; Razak A; Goldstein D; Shi W; Liu FF; Xu W; O'Sullivan B
    Cancer; 2015 Feb; 121(4):545-55. PubMed ID: 25336438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Human Papillomavirus and p16 Status With Outcomes in the IMCL-9815 Phase III Registration Trial for Patients With Locoregionally Advanced Oropharyngeal Squamous Cell Carcinoma of the Head and Neck Treated With Radiotherapy With or Without Cetuximab.
    Rosenthal DI; Harari PM; Giralt J; Bell D; Raben D; Liu J; Schulten J; Ang KK; Bonner JA
    J Clin Oncol; 2016 Apr; 34(12):1300-8. PubMed ID: 26712222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oropharyngeal cancer is no longer a disease of younger patients and the prognostic advantage of Human Papillomavirus is attenuated among older patients: Analysis of the National Cancer Database.
    Rettig EM; Zaidi M; Faraji F; Eisele DW; El Asmar M; Fung N; D'Souza G; Fakhry C
    Oral Oncol; 2018 Aug; 83():147-153. PubMed ID: 30098771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deintensification candidate subgroups in human papillomavirus-related oropharyngeal cancer according to minimal risk of distant metastasis.
    O'Sullivan B; Huang SH; Siu LL; Waldron J; Zhao H; Perez-Ordonez B; Weinreb I; Kim J; Ringash J; Bayley A; Dawson LA; Hope A; Cho J; Irish J; Gilbert R; Gullane P; Hui A; Liu FF; Chen E; Xu W
    J Clin Oncol; 2013 Feb; 31(5):543-50. PubMed ID: 23295795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Prognostic Value of Baseline 18F-FDG PET/CT in Human Papillomavirus-Positive Versus Human Papillomavirus-Negative Patients With Oropharyngeal Cancer.
    Gouw ZAR; La Fontaine MD; van Kranen S; van de Kamer JB; Vogel WV; van Werkhoven E; Sonke JJ; Al-Mamgani A
    Clin Nucl Med; 2019 May; 44(5):e323-e328. PubMed ID: 30889002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor volume as a prognostic marker in p16-positive and p16-negative oropharyngeal cancer patients treated with definitive intensity-modulated radiotherapy.
    Carpén T; Saarilahti K; Haglund C; Markkola A; Tarkkanen J; Hagström J; Mattila P; Mäkitie A
    Strahlenther Onkol; 2018 Aug; 194(8):759-770. PubMed ID: 29774396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double positivity for HPV-DNA/p16
    Mena M; Taberna M; Tous S; Marquez S; Clavero O; Quiros B; Lloveras B; Alejo M; Leon X; Quer M; Bagué S; Mesia R; Nogués J; Gomà M; Aguila A; Bonfill T; Blazquez C; Guix M; Hijano R; Torres M; Holzinger D; Pawlita M; Pavon MA; Bravo IG; de Sanjosé S; Bosch FX; Alemany L
    Oral Oncol; 2018 Mar; 78():137-144. PubMed ID: 29496041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Refining American Joint Committee on Cancer/Union for International Cancer Control TNM stage and prognostic groups for human papillomavirus-related oropharyngeal carcinomas.
    Huang SH; Xu W; Waldron J; Siu L; Shen X; Tong L; Ringash J; Bayley A; Kim J; Hope A; Cho J; Giuliani M; Hansen A; Irish J; Gilbert R; Gullane P; Perez-Ordonez B; Weinreb I; Liu FF; O'Sullivan B
    J Clin Oncol; 2015 Mar; 33(8):836-45. PubMed ID: 25667292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of the ICON-S staging for HPV-associated oropharyngeal carcinoma using a pre-defined treatment policy.
    Porceddu SV; Milne R; Brown E; Bernard A; Rahbari R; Cartmill B; Foote M; McGrath M; Coward J; Panizza B
    Oral Oncol; 2017 Mar; 66():81-86. PubMed ID: 28249652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detailed Analysis of Clinicopathologic Factors Demonstrate Distinct Difference in Outcome and Prognostic Factors Between Surgically Treated HPV-Positive and Negative Oropharyngeal Cancer.
    Iyer NG; Dogan S; Palmer F; Rahmati R; Nixon IJ; Lee N; Patel SG; Shah JP; Ganly I
    Ann Surg Oncol; 2015 Dec; 22(13):4411-21. PubMed ID: 25801358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of estrogen receptor alpha is associated with pathogenesis and prognosis of human papillomavirus-positive oropharyngeal cancer.
    Kano M; Kondo S; Wakisaka N; Wakae K; Aga M; Moriyama-Kita M; Ishikawa K; Ueno T; Nakanishi Y; Hatano M; Endo K; Sugimoto H; Kitamura K; Muramatsu M; Yoshizaki T
    Int J Cancer; 2019 Sep; 145(6):1547-1557. PubMed ID: 31228270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer stem cell enrichment marker CD98: a prognostic factor for survival in patients with human papillomavirus-positive oropharyngeal cancer.
    Rietbergen MM; Martens-de Kemp SR; Bloemena E; Witte BI; Brink A; Baatenburg de Jong RJ; Leemans CR; Braakhuis BJ; Brakenhoff RH
    Eur J Cancer; 2014 Mar; 50(4):765-73. PubMed ID: 24315751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring the Impact of Human Papillomavirus Status, Comorbidity, Polypharmacy, and Treatment Intensity on Outcome of Elderly Oropharyngeal Cancer Patients Treated With Radiation Therapy With or Without Chemotherapy.
    Caparrotti F; O'Sullivan B; Bratman SV; Ringash J; Lu L; Bayley A; Cho J; Giuliani M; Hope A; Kim J; Waldron J; Hansen A; Goldstein D; Perez-Ordonez B; Weinreb I; Tong L; Song Y; Xu W; Huang SH
    Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):858-867. PubMed ID: 28258893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of retropharyngeal adenopathy on distant control and survival in HPV-related oropharyngeal cancer treated with chemoradiotherapy.
    Samuels SE; Vainshtein J; Spector ME; Ibrahim M; McHugh JB; Tao Y; Schipper M; Worden F; Eisbruch A
    Radiother Oncol; 2015 Jul; 116(1):75-81. PubMed ID: 26094074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poor prognosis in human papillomavirus-positive oropharyngeal squamous cell carcinomas that overexpress hypoxia inducible factor-1α.
    Swartz JE; Pothen AJ; van Kempen PM; Stegeman I; Formsma FK; Cann EM; Willems SM; Grolman W
    Head Neck; 2016 Sep; 38(9):1338-46. PubMed ID: 27027530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment de-escalation for HPV+ oropharyngeal cancer: A systematic review and meta-analysis.
    Petrelli F; Luciani A; Ghidini A; Cherri S; Gamba P; Maddalo M; Bossi P; Zaniboni A
    Head Neck; 2022 May; 44(5):1255-1266. PubMed ID: 35238114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leukocytosis and neutrophilia predicts outcome in anal cancer.
    Schernberg A; Escande A; Rivin Del Campo E; Ducreux M; Nguyen F; Goere D; Chargari C; Deutsch E
    Radiother Oncol; 2017 Jan; 122(1):137-145. PubMed ID: 28024835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.